| Federico Rivas-gotz, MD | |
|
5514 Corporate Dr Ste 120, Saint Joseph, MO 64507-7754 | |
| (816) 271-1350 | |
| (816) 271-1355 |
| Full Name | Federico Rivas-gotz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 5514 Corporate Dr Ste 120, Saint Joseph, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053354092 | NPI | - | NPPES |
| 205998503 | Medicaid | MO | |
| 200598670A | Medicaid | KS | |
| P00752887 | Other | MO | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2002023849 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mosaic Life Care Home Health | Saint joseph, MO | Home health agency |
| Mosaic Life Care Hospice | Saint joseph, MO | Hospice |
| Mosaic Life Care At St Joseph | Saint joseph, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heartland Regional Medical Center | 6709772767 | 342 |
News Archive
A researcher at Charles Drew University of Medicine and Science is investigating the potential use of non-pathogenic baker's yeast as a promising, natural therapy for cancer.
Actavis Group, the international generic pharmaceuticals company, today announced that its third-party sales division, Medis, has delivered 30 million tablets of Atorvastatin to its clients in Spain. This is the first generic version of the blockbuster molecule to reach the Spanish market.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has agreed that BioVex's ongoing OPTiM clinical study in unresectable Stage IIIb-IV melanoma be amended to include untreated (i.e., first line) patients as well as previously treated patients as defined in the original protocol.
NPR interviewed Rep. Dave Camp, ranking Republican on the House Ways and Means Committee. Camp said: "We were able to at least be heard and have some exposure to the ideas that we've been promoting for a long time. And the president did finally say in the close that we do have ideas that lower costs in insurance and that — do it without increasing taxes. And we don't cut Medicare. And we don't have new mandates in our proposals. So this is really the first opportunity we've had to really focus not only our colleagues and the president, but also the American people on the proposals we've had" (Siegel, 2/25).
› Verified 4 days ago
| Entity Name | Heartland Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477575405 PECOS PAC ID: 6709772767 Enrollment ID: O20040225001201 |
News Archive
A researcher at Charles Drew University of Medicine and Science is investigating the potential use of non-pathogenic baker's yeast as a promising, natural therapy for cancer.
Actavis Group, the international generic pharmaceuticals company, today announced that its third-party sales division, Medis, has delivered 30 million tablets of Atorvastatin to its clients in Spain. This is the first generic version of the blockbuster molecule to reach the Spanish market.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has agreed that BioVex's ongoing OPTiM clinical study in unresectable Stage IIIb-IV melanoma be amended to include untreated (i.e., first line) patients as well as previously treated patients as defined in the original protocol.
NPR interviewed Rep. Dave Camp, ranking Republican on the House Ways and Means Committee. Camp said: "We were able to at least be heard and have some exposure to the ideas that we've been promoting for a long time. And the president did finally say in the close that we do have ideas that lower costs in insurance and that — do it without increasing taxes. And we don't cut Medicare. And we don't have new mandates in our proposals. So this is really the first opportunity we've had to really focus not only our colleagues and the president, but also the American people on the proposals we've had" (Siegel, 2/25).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Federico Rivas-gotz, MD 5514 Corporate Dr Ste 120, Saint Joseph, MO 64507-7754 Ph: (816) 271-1350 | Federico Rivas-gotz, MD 5514 Corporate Dr Ste 120, Saint Joseph, MO 64507-7754 Ph: (816) 271-1350 |
News Archive
A researcher at Charles Drew University of Medicine and Science is investigating the potential use of non-pathogenic baker's yeast as a promising, natural therapy for cancer.
Actavis Group, the international generic pharmaceuticals company, today announced that its third-party sales division, Medis, has delivered 30 million tablets of Atorvastatin to its clients in Spain. This is the first generic version of the blockbuster molecule to reach the Spanish market.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has agreed that BioVex's ongoing OPTiM clinical study in unresectable Stage IIIb-IV melanoma be amended to include untreated (i.e., first line) patients as well as previously treated patients as defined in the original protocol.
NPR interviewed Rep. Dave Camp, ranking Republican on the House Ways and Means Committee. Camp said: "We were able to at least be heard and have some exposure to the ideas that we've been promoting for a long time. And the president did finally say in the close that we do have ideas that lower costs in insurance and that — do it without increasing taxes. And we don't cut Medicare. And we don't have new mandates in our proposals. So this is really the first opportunity we've had to really focus not only our colleagues and the president, but also the American people on the proposals we've had" (Siegel, 2/25).
› Verified 4 days ago
Dr. Andre Joel Arsenault, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5325 Faraon St, Saint Joseph, MO 64506 Phone: 816-271-6406 Fax: 816-271-7986 | |
Robert C Clark, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Heartland Rd, Ste 3800, Saint Joseph, MO 64506 Phone: 816-671-4800 Fax: 816-233-4021 | |
Issam El Bizri, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5325 Faraon St, Saint Joseph, MO 64506 Phone: 816-271-6406 Fax: 816-271-7986 | |
Bradley R Dyer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5325 Faraon St, Ms 1020 Division Of General And Geriatric Medicine Univ, Saint Joseph, MO 64506 Phone: 816-271-6406 | |
Gita G Sprague, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5514 Corporate Dr Ste 120, Saint Joseph, MO 64507 Phone: 816-271-1350 Fax: 816-271-1355 | |
Dr. Vijay Kanakadandi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 802 N Riverside Rd Ste 220, Saint Joseph, MO 64507 Phone: 816-271-6155 |